• Engineered Klotho mRNA Delivery Rejuvenates Senescent iMSCs

  2026-07-27

  This study introduces a hyperbranched poly(β-amino ester) (HPAE)-based system for delivering engineered Klotho mRNA to aged and Klotho-deficient induced mesenchymal stem cells (iMSCs), demonstrating rapid reversal of cellular senescence and restoration of homeostasis. The findings highlight the promise of mRNA therapeutics in regenerative medicine, particularly for age-associated dysfunction.

• (+)-Bicuculline: Protocols and QC for GABAA Antagonist Use

  2026-07-27

  (+)-Bicuculline provides reliable, competitive antagonism of GABAA receptors for dissecting inhibitory neurotransmission and synaptic NMDA receptor signaling. It is designed for controlled neuroscience workflows and is not suitable for diagnostic or clinical applications. Precise attention to solubility, storage, and workflow parameters is essential for consistent results.

• Triamcinolone Technical Guidance for Synthetic Glucocorticoi

  2026-07-26

  Triamcinolone addresses the need for a reliable synthetic glucocorticoid agonist in controlled in vitro research of glucocorticoid signaling, inflammation, and immunosuppression mechanisms. It is not intended for diagnostic or therapeutic use and requires precise handling due to its solubility and storage characteristics.

• DMG-PEG2000-NH2: Redefining LNP Design for Translational Suc

  2026-07-25

  This thought-leadership article explores the mechanistic, experimental, and translational impact of DMG-PEG2000-NH2 as a next-generation NH2-PEG derivative for lipid-based drug delivery. Integrating evidence from recent antimicrobial optimization studies, it provides protocol guidance, competitive analysis, and actionable insights for researchers seeking to leverage this amine PEG linker in advanced bioconjugation and therapeutic workflows.

• Dynamics of Carbapenemase Genes in Enterobacter cloacae Duri

  2026-07-24

  This study systematically characterizes carbapenemase-encoding gene (CEG) carriage and transmission in carbapenem-resistant Enterobacter cloacae (CREC) from eight teaching hospitals in Guangdong, China, during the COVID-19 era. Its findings illuminate the dominant role of plasmid-borne blaNDM-1 and the high transferability of resistance genes, with direct implications for antimicrobial resistance research and infection control.

• LY294002: Applied Protocols for PI3K/Akt/mTOR Pathway Analys

  2026-07-24

  LY294002, also known as 2-(4-Morpholinyl)-8-phenyl-4H-l-benzopyran-4-one, enables precise, reversible inhibition of class I PI3Ks for dissecting signaling, autophagy, and apoptosis in cancer and neuroinflammatory models. This article delivers actionable workflow enhancements, protocol optimizations, and troubleshooting strategies to maximize reproducibility and insight across diverse biological research domains.

• BML-277: Precision Chk2 Inhibitor for DNA Damage Response As

  2026-07-23

  BML-277 brings unparalleled selectivity and potency as a Chk2 inhibitor, enabling researchers to dissect DNA damage response pathways and achieve reproducible T-cell radioprotection. Its robust ATP-competitive inhibition and compatibility with advanced kinase assays set new standards for mechanistic clarity in both basic and translational research.

• SB 202190 as a p38 MAP Kinase Inhibitor in Neuroinflammation

  2026-07-23

  SB 202190 stands out as a gold-standard p38 MAP kinase inhibitor for dissecting neuroinflammatory pathways and apoptosis mechanisms. This article demystifies its workflow integration, highlights experimental innovation from astrocyte-microglia crosstalk research, and provides actionable troubleshooting insights.

• Genetic Tools Enhance A40926 Production in Nonomuraea spp.

  2026-07-22

  Yushchuk et al. (2020) developed new molecular tools to improve A40926 glycopeptide antibiotic yields in Nonomuraea gerenzanensis. Their work provides a genetic framework for optimizing precursor supply for dalbavancin and advances rational strain improvement for antibiotic discovery.

• ZIF8 Nanotheranostic Platform for Targeted TNBC Therapy and

  2026-07-22

  Li et al. (2026) introduce a folic acid–PEG–modified ZIF8 nanoplatform for targeted delivery of ciprofloxacin, enabling ultrasound-guided, synergistic therapy in triple-negative breast cancer (TNBC). The study demonstrates enhanced tumor targeting, immune activation, and imaging capability, positioning this system as a promising approach for integrated diagnosis and treatment.

• β-Sitosterol Upregulates TBX20 to Suppress Colorectal Cancer

  2026-07-21

  This study demonstrates that β-sitosterol, a key component of Herba Sarcandrae, inhibits colorectal cancer progression by stabilizing and upregulating the tumor suppressor TBX20. These findings suggest a novel, multi-targeted therapeutic strategy and highlight the value of network pharmacology for cancer therapeutics research.

• Elobixibat Hydrate: Translational Leverage for Bile Acid Mod

  2026-07-21

  This thought-leadership article explores the mechanistic underpinnings and strategic translational applications of Elobixibat hydrate, a selective ileal bile acid transporter inhibitor. Integrating evidence from mechanistic studies, clinical pilot trials, and competitive research workflows, we provide actionable guidance for researchers aiming to harness enterohepatic bile acid modulation in chronic idiopathic constipation, metabolic diseases, and colonoscopy preparation. The article distinguishes itself by bridging mechanistic clarity with workflow optimization, highlighting unique translational opportunities and forward-looking strategies.

• Recombinant Mouse IFN-γ: Catalyzing Tumor Antigenicity Resea

  2026-07-20

  This article addresses the mechanistic and translational challenges of restoring antigen presentation in immunometabolic liver cancer, highlighting the pivotal role of Recombinant Mouse IFN-γ. We synthesize recent mechanistic insights on bile acid-mediated immune escape in MASH-HCC, offer strategic guidance for leveraging cytokine pathways in experimental models, and position APExBIO’s high-purity IFN-γ as an indispensable asset for translational researchers aiming to unlock new immunotherapeutic strategies.

• Estradiol Benzoate: Redefining Estrogen Receptor Alpha Resea

  2026-07-20

  This thought-leadership article dissects the mechanistic and translational impact of Estradiol Benzoate as an estrogen receptor alpha agonist, guiding researchers through protocol optimization, competitive landscape, and emerging strategic directions. Integrating recent advances in proteomics and inhibitor screening, the discussion positions APExBIO's Estradiol Benzoate as an indispensable tool for next-generation hormone receptor signaling research.

• Nutlin-3a: MDM2 Inhibitor Workflows for Precision Cancer Res

  2026-07-19

  Nutlin-3a from APExBIO enables robust, reproducible activation of the p53 pathway via targeted MDM2 inhibition, empowering cancer researchers to dissect cell cycle, apoptosis, and drug synergy in both wild-type and mutant p53 contexts. This guide delivers actionable protocols, troubleshooting insights, and translational lessons from the latest glioblastoma research.

16122 records 1/1075 page Next 12345 下5页 Last page